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Introduction 50
Over the past half century in the United States the prevalence of obesity, defined as body 51 . This includes 67 prostate cancer, for which obesity increases progression but not incidence 8 . Here, we 68 discuss (with a focus on developing mechanism-based intervention strategies) many ways 69 in which obesity can influence normal epithelial tissue homeostasis and cancer 70 development and/or progression, including metabolic perturbations involving hormonal, 71 8 in epithelial cancers 21 . In response to these growth factors and nutrient availability, 141 PI3K/Akt produces lipid messengers that initiate the Akt signaling cascade 21 , activating 142 downstream mammalian target of rapamycin (mTOR) 22 . When activated mTOR initiates 143 downstream signaling that promotes cell growth, proliferation and survival. In response 144
to low nutrient conditions AMP-activated kinase (AMPK), another energy responsive 145 pathway, inhibits mTOR activation and downstream signaling 23 . Oncogenic signals or 146 loss of tumor suppressors can activate mTOR and contribute to the hallmarks of cancer, 147 promoting proliferation, survival, angiogenesis, and metastasis 24 . In preclinical models, 148 blocking mTOR signaling with drugs such as rapamycin (mTOR inhibitor) [25] [26] [27] and 149 metformin (AMPK activator) 25, 28, 29 , block tumor-enhancing effects associated with the 150 obese phenotype 
Altered Adipose Secretome 176
Leptin is an energy-sensing peptide hormone produced by adipocytes. Leptin levels, 177 positively correlated with adiposity, function as an energy sensor through signaling to the 178 hypothalamus, decreasing hunger cues, food intake and weight gain. Leptin release from 179 adipocytes is stimulated by a variety of factors including insulin, TNFα, glucocorticoids, 180 and estrogen 34 . In obesity, leptin is overproduced by adipocytes, reducing hypothalamic 181 sensitivity to the signal 35 . Circulating leptin binds to various receptors in central nervous 182 system and peripheral tissues, regulating processes including energy homeostasis, 183 cytokine production, immune function, and carcinogenesis 34, 36 . The leptin receptor OB-R, 184
classified as a class I cytokine receptor, gives leptin the ability to activate signal 185 
Calorie Restriction 337
Calorie restriction (CR), defined as reduction of dietary energy intake without 338 malnutrition, is broadly effective dietary intervention that significantly decreases 339
adiposity. Preclinical models demonstrate 30% CR, compared with ad libitum-fed 340 control, ameliorates risk factors and delays onset of cancer through metabolic alterations 341 fostering increased insulin sensitivity and decreased serum glucose, growth factor 342 signaling, inflammation, oxidative stress and angiogenesis [82] [83] [84] [85] . These metabolic changes 343 translate into significantly decreased cancer incidence in murine models 86 . Due to long 344 latency of cancer in humans, the literature does not have data linking CR directly with 345 cancer incidence in humans. However, randomized control trials implementing long-term 346 20% CR in overweight human subjects has confirmed reduced adiposity, improved 347 glucose homeostasis, increased adiponectin, and reduced leptin and inflammatory 348 markers TNF and C-reactive protein 87, 88 . Substantial weight loss of >10% may be 349 necessary to consistently gain these benefits [89] [90] [91] . 
Ketogenic Diet 439
Ketogenic diet (KD) is a very-low carbohydrate diet with high fat and moderate protein 440 composition. Low carbohydrate consumption reduces available glucose, a cancer cell's 441 preferred energy source, and increases catabolism of proteins and fats to provide 442 gluconeogenic glucose and ketones. With prolonged consumption of KD, glycogen stores 443 reach critical levels and the body is no longer able to oxidize fats to glucose via 444 gluconeogenesis. This results in a shift to increased ketone production and physiological 445 ketosis. Ketosis is not to be confused with ketoacidosis that is seen with diabetes mellitus. 446
In ketosis there is less accumulation of ketones, as they are being used efficiently by the 447 brain and body as an energy source, and individuals do not experience adverse side 448 effects associated with ketoacidosis 124 . Ketosis from KD favorably modulates many 449 cancer risk biomarkers including IGF-1, leptin, adiponectin, inflammatory markers, and 450 angiogenic factors ( Figure 5 ) [125] [126] [127] [128] . Preclinical studies suggest that KD can attenuate 451 these markers without a reduction in caloric intake; however, weight loss may be 452 needed 129, 130 . KD may induce weight loss via several interrelated mechanisms, including: 453 reduced appetite due to high protein intake, which can induce higher satiety, and high 454 ketones, known to modulate appetite-regulating hormones; reduced caloric intake due to 455 the satiety; reduced lipogenesis and increased lipolysis; greater metabolic efficiency; and 456 increased metabolic cost of gluconeogenesis and ketogenesis 
